The value of positive scans of autologous 'Tc-labelled leucocytes in the detection of intestinal inflammation was assessed in 29 patients with known inflammatory bowel disease and a high probability of intestinal inflammation and 58 with a low probability of intestinal inflammation comprising 37 with intestinal symptoms and 21 with suspected abscess. Autologous leucocytes were labelled with 9mTc using either of the established methods. In patients with inflammatory bowel disease, 3/13 with ileocaecal and 1/11 with colonic accumulation of 99Tc were incorrectly diagnosed in that there was no histological evidence of inflammation in those regions. In the low probability patients, all 26 positive images were false positives: there were 19 in the ileocaecal and 7 in colonic regions and no differences between the two subgroups. False positives were more common in low probabilitythanhigh probabilitypatients (p=0.011). The results were independent of the 'Tc cell labelling technique used. Three false positive patients also had normal scans for "'lInlabelled granulocytes. The time of first detection of 'Tc in the bowel was earlier in true than in false positive patients (92% v 33% within 1 h, p=0.008), the false positive rates in the first hour of imaging being 5% in high and 15% in low probability patients. In -Tc scinti-
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been sought and two apparently satisfactory methods using the readily available y-emitting isotope, 9mTc, have been developed.0'-'5 The images produced by such methods are of generally better resolution than for "'In and the radiation dosage delivered to organs such as the spleen is considerably less. The ability to measure faecal excretion quantitatively, however, is limited" 12 by the very short half-life of 99-Tc.
'Tc scintigraphy using autologous leucocytes has been evaluated by a number ofinvestigations in patients with a high probability of intestinal inflammation (patients with IBD) and these have indicated that, like "'In-labelled granulocyte scans, they have a high sensitivity of detection of inflammation and perform well in disease localisation. '-'4 However, no studies have systematically examined their use in disease controls, especially in patients with abdominal symptoms but a low probability of intestinal inflammation, so that specificity may be more accurately assessed. Intestinal accumulation of 9'Tc is reported to occur three or more hours"`or even within the first hour'9 after reinjection of labelled leucocytes in subjects with normal bowels when the hexamethyl propylene amine oxime (HMPAO) method is used but has not been observed when leucocytes are labelled with 9Tc-stannous colloid. The aims of this study were to examine the ability ofpositive scans to predict the presence ofintestinal inflammation in patients with either a high or low probability of having such inflammation and to compare the performance of the two methods of cell labelling. (Little Chalfont, England). 9mTc was complexed to either a stannous fluoride colloid (Radiopharm, Canberra) or to HMPAO as previously described. '3 Leucocyte labelling Leucocytes were labelled with`OmTc-stannous fluoride colloid as previously reported.' 12 21 Briefly, 20 ml of peripheral blood was drawn into a heparinised plastic syringe and incubated for 1 h with 166-629 (mean 324) MBq of 99mTc-stannous colloid. Excess colloid was removed by centrifugation and the cells gently resuspended in normal saline and reinfused into the patient. Labelling efficiency was always greater than 95%.
The method for labelling leucocytes with 'Tc-HMPAO was similar to that previously reported.'3 Briefly, 50 ml of peripheral blood was collected using acid citrate dextrose (NIH formula A) as anticoagulant and transferred to five 10 ml tubes each containing 0.5 ml of 2% methylcellulose in normal saline. After sedimentation of red cells for 30-45 min, the supernatant was aspirated and centrifuged at 70-80 g for 7 min. The cell pellet was resuspended in normal saline and incubated for 15 min at room temperature with freshly prepared "-Tc-HMPAO. The cells were washed once, resuspended in autologous leucocyte-poor plasma, and returned to the patient. Labelling efficiency (mean (SEM)) was 56 (3)% and the patients received 100-592 (mean 285) MBq of '9Tc.
"'In labelling of purified granulocytes was carried out by a modification of a previously reported method. 2 In order to purify granulocytes, leucocytes were first isolated from 50 ml peripheral blood as described above and were then sedimented over a discontinuous FicollPaque (Pharmacia) gradient. The cell pellet was retained, washed twice in autologous plasma, and incubated for 10 mins in 2 ml plasma containing 120 MBq of "'In oxine. After washing them in plasma, the cells were returned to the patient. In preliminary experiments, both 'Tc-HMPAO-labelled leucocytes and "'In-labelled granulocytes had a viability of >95%, as shown by 0' 1% trypan blue exclusion. two patients and grade 1 in one). In two patients with Crohn's disease, the mucosa of terminal ileum to mid-transverse colon was normal at colonoscopy and ileoscopy, and barium small bowel follow through examination was normal. The third patient had a total colectomy for ulcerative colitis, and the ileum was found to be normal at surgical evaluation and by histology of the ileal stump (Fig 1) . Eleven patients had positive scans in regions of the colon other than the caecum but one of these, in a patient who had surgical resection of severely inflamed ileum, was falsely positive (grade 3) in the ascending and transverse colon as early as 30 minutes after reinjection of labelled leucocytes. No patient had false positive "mTc accumulation in both anatomical regions. Thus, four (14%) of the 29 patients with high probability of intestinal inflammation had false positive scans.
In the low probability group, 17 (46%) of the 37 patients in the '?IBD' group and nine (43%) of the 21 patients in the '?abscess' group had positive scans, uptake being seen in the ileocaecal area in 15 and four patients and in the colon in two and five patients respectively. Two examples are shown in Figure 2 . In none of the patients in this group was a definitive diagnosis of IBD made and all scans were apparently falsely positive. The positive images were obtained 4 h after reinfusion of cells in two patients, 3 h in four, and 0 5-2 h in the remainder. Uptake in the ileocaecal region was grade 2 in four patients and grade 3 in the other 15 and, in the colon, was grade 1 in two, grade 2 in two, and grade 3 in three. Investigation of '?IBD' patients with positive scans was thorough and included markers ofinflammation (leucocyte count, erythrocyte sedimentation rate and/or C-reactive protein) in all patients, barium studies (10 small bowel, 4 large bowel), flexible sigmoidoscopy (2) , colonoscopy (14) , and ileoscopy (12) . During all endoscopic procedures, multiple biopsies were taken for histopathological assess- ment. The only abnormal findings comprised one patient with an elevated C-reactive protein and another with a mildly elevated erythrocyte sedimentation rate, both of whom had normal barium follow through studies as well as normal colonoscopy and ileoscopy. In addition, clinical follow up of these patients has exceeded 12 months for 10 without a change from the diagnosis of irritable bowel syndrome. Patients with positive images in the '?abscess' group were not specifically investigated for intestinal inflammation but in none were there clinical indicators of intestinal inflammation. Thus, the false positive rate (26/58 patients) in the low probability group was 44% which was significantly higher than that in the high probability patients (p=0.01 1).
In an attempt to differentiate false from true positive scans, 27 patients were serially imaged over the first 3 h to examine the pattern of migration of 99mTc and the time of first appearance of 99mTc in the intestine. Neither the rapidity of luminal transit of "ImTc nor persistence ofactivity at the original site of uptake were good discriminators. In 15 patients whose scans were false positive, 10 had an initially negative image (within 1 h of reinjection) and became positive at 2 h in nine and 3 h in one. In the other five, the image within the first hour was positive, being grade 1 in one patient and grades 2 and 3 in two patients each. By comparison, in the 12 patients with true positive scans, 99mTc appeared in the intestine within the first hour in 11 (92%). This was a significantly greater proportion than for false positive scans (p=0.008). Thus, if detection of 'mTc accumulation only within the first hour was considered positive, the false positive rate would fall to 5% for high probability and to 15% for low probability patients while the sensitivity would be reduced by only an estimated 8%.
The accuracy of the true positive images obtained within the first hour was assessed by comparing the regional extent and degree of 'Tc uptake with those of autologous 2 h or 3 h scans and by correlating the scan grade with the histopathological severity in that region. The results are illustrated in Figure 3 and two examples are shown in Figure 4 . Scanning within the first hour performed well in the distal small bowel, caecum, and left side of the colon but had reduced sensitivity in the transverse colon where it failed to detect inflammation in two of five patients. The grading of early images with respect to uptake in the iliac crests was, however, worse than 2-3 h assessment as a predictor of histopathological severity.
The reproducibility of false positive scans was assessed in eight patients who had scans from two days to 20 months apart. In five patients, the original results were reproduced (two days, three days, one month, three months, and 17 months apart) while in three, the image changed, becoming negative in two (three months and 15 months apart) and positive in one (20 months apart).
The stannous colloid method for 99mTc-labelling of phagocytic leucocytes was used in 58 patients while the HMPAO method of cell labelling was used in 33. The false positive rate was similar for each method, being 38% and 30% respectively and no differences were seen when high and low probability groups were examined separately. The time of first appearance of 99mTc in the bowel was also similar, two with the colloid method and three with the HMPAO method becoming positive within the first hour. Four patients had dual scans within four weeks of each other using different labelling methods on each occasion and, in every case, the results were the same. Thus, the false positive problem appeared to be independent of the method used for labelling leucocytes with 99mTc.
As the high specificity and sensitivity of autologous "'In-labelled granulocyte scintigraphy to intestinal inflammation has been previously validated,' 4 three patients with false positive 9Tc scans were examined either simultaneously or subsequently within two weeks using "'In-labelled cells. On every occasion, the "'In scan was negative even in late (24 h) films (Fig 5) . Discussion Ofcritical importance to the interpretation of the data in this study is the confidence by which intestinal inflammation was excluded in patients with false positive scans. All patients with IBD included in the study had unequivocal assessment ofdisease distribution and activity and, therefore, false positive scans were investigated and confirmed. In the ?IBD group, mucosal normality was proven in both patients with colonic accumulation (transverse colon and splenic flexure) and 10 of 15 patients with ileocaecal accumulation of 99mTc by histological examination of biopsies from the suspicious regions of the intestines. Of the remaining five patients, four were radiologically normal whereas one had neither radiological nor endoscopic assessment but had negative scintigraphy of "'In-labelled granulocytes. Though specific intestinal investigation was not undertaken in '?abscess' patients with positive scans, there were no clinical pointers to intestinal disease except the possibility of ileal disease induced by non-steroidal anti-inflammatory drugs in one. Moreover, the absence of intestinal inflammation in three falsepositive '?IBD' patients was confirmed on "'In scintigraphy, a technique with high sensitivity and specificity for such inflammation.A4 It can, therefore, be said with confidence that at least the majority of patients with apparently false positive scans had no intestinal inflammation at the site of 99mTc accumulation.
Most published studies of autologous leucocyte 99mTc scintigraphy using either "-Tc-HMPAO or 99Tc-colloid methods have not reported high false positive rates. Reasons for the discrepancy may be due partly to too few healthy subjects or low probability patients being examined. In other words, previous reports have dealt almost exclusively with patients carrying a high probability of intestinal inflammation,1''2 14'5 many of whom have not had complete histopathological assessment of disease activity in the relevant subregions of the small and large bowel within a short time of imaging. Without these focal examinations, false positive scans may easily be overlooked. In the minority of patients with simultaneous true and false positive sites of 'Tc accumulation (as demonstrated in Fig 1) , it is possible though less likely that rapid luminal transit of "-Tc either distally or proximally from the inflamed area may explain the incorrect localisation. Normal intestinal accumulation of 'Tc is known to occur when the HMPAO method is used but only after three or more hours have elapsed after reinjection of the radiolabelled cells'3"518 though one study found normal intestinal uptake as early as 30 min. 19 Such early uptake has not been reported for 9"mTc-colloid labelled leucocytes and has been proposed as a distinct advantage of that labelling method. 12 Normal intestinal accumulation seen in the present study occurred within 3 h and, in 15%, within the first hour, figures which closely mimic those of Costa et al for "-Tc-HMPAO labelled cells.'9 However, this early accumulation occurred independently of the method of tagging 99mTc to leucocytes.
The possibility that these observations relate to difficulties with technique appears unlikely as the methodology used closely followed the published methods, all cell populations were labelled by a scientist highly experienced in similar celllabelling procedures, and labelling efficiencies were always as high as ' With such high false positive rates, the clinical value of 99-Tc-labelled leucocyte scintigraphy in the detection of intestinal inflammation will depend upon the ability to differentiate true from false positive scans. On serial images, the pattern of migration down the intestinal lumen was a poor discriminator. However, 99mTc accumulation occurs earlier in true positive patients, with significantly more having positive images within the first hour after reinjection of the labelled cells. If interpretation were modified such that only scans with uptake initially seen within the first hour were considered positive, the sensitivity of detection of intestinal inflammation would be reduced by only 8% while the false positive rate would fall by two-thirds. Thus, in patients with known IBD, the false positive rate would be only 5% while the high sensitivity, as previously reported' 14 and also found by us (unpublished observations), would be only slightly reduced, a performance that is clinically acceptable. Moreover, the assessment ofdisease extent was similar for the 1 h scan as for conventional 2 h and 3 h scans except for transverse colon. Grading the 1 h scans relative to iliac crest uptake was, however, inferior to later scans at predicting severity ofinflammation. In contrast, a false positive rate of 15% in low probability patients is still not specific enough for 99mTc-labelled leucocyte scintigraphy to be useful as a predictor of the presence of intestinal inflammation.
In conclusion, a high rate of false positive scans occurs when 99mTc is used to label autologous leucocytes due to non-specific intestinal accumulation. This rate can be substantially reduced by considering only intestinal uptake within 1 h of reinjection of labelled cells as truly positive for inflammation. Using this method of interpretation, 'Tc-labelled leucocyte scintigraphy performs well enough to maintain clinical usefulness in patients with known IBD despite a small reduction in sensitivity. However, the scans do not have acceptable specificity in patients with a low probability of intestinal inflammation and, therefore, have no role as positive predictors ofinflamed bowel in patients with abdominal symptoms suggestive of IBD.
